News Bunkers – Global News Updates

Latest AI, Tech & Global News Updates

Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success – WSJ

  1. Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success  WSJ
  2. Triple-action diabetes jab shown to reduce blood sugar and body weight  The Guardian
  3. Retatrutide Data Show Dramatic Weight Loss, Other Benefits  Medscape
  4. Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits  Reuters
  5. Lilly’s 30% Weight Loss Sets High Bar for Obesity Drug Race  Bloomberg.com

source

Leave a Reply

Your email address will not be published. Required fields are marked *